2HD-19118-72961 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-24
Registered in v-safe
2021-03-24
Dose 1 — Janssen/Johnson & Johnson
2021-03-24
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain, Swelling · Nausea · Be unable to work

Adult check-in
2021-03-24
Report sent to call center — day 0, dose 1
Be unable to work

1 call case(s)
2021-03-25
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-03-25
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-03-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Nausea, Vomiting · Be unable to work

Adult check-in
2021-03-27
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2021-03-31
Health check-in — day 7, dose 1
Feeling: Good · Nausea

Adult check-in
2021-04-09
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-24	Janssen/Johnson & Johnson

Call center

Reported	Outcome	VAERS-related outcome
2021-03-24	priority 2/3
2021-03-25	priority 2/3
2021-03-27	priority 2/3

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.